Immuno-Oncology Research

Publish Date:
October 23, 2017
Authors:
Chiltern Staff

Immuno-oncology is one of the most active areas of cancer research today. From interleukin-2 (IL-2) immunotherapies, to the more recent advent of PD-1 and PD-L1 inhibitors, CAR-T cell therapies and personalized vaccines, immuno-oncology is a vibrant area of groundbreaking research, with a growing number of active trials around the world.

When you need insight to guide you to the best outcome for your next immuno-oncology trial, Chiltern has experienced professionals and extensive services Designed Around You®.

Fields marked with an * are required